Apple has successfully persuaded a federal judge to dismiss a lawsuit filed by a Silicon Valley startup concerning alleged monopolistic practices in the US market for heart rate monitoring applications designed for the Apple Watch, as reported by Reuters.
The ruling, delivered by US District Judge Jeffrey White in Oakland, California, rejected claims brought forth by AliveCor, a company known for its development of an application aimed at detecting irregular heartbeats. AliveCor had accused Apple of violating both federal antitrust laws and California’s unfair competition regulations.
Details regarding Judge White’s rationale behind the decision have been temporarily withheld from the public due to confidentiality concerns.
ALSO READ: WATCH VIDEO | Driving Tesla, Walking Robot Dog, More: Apple Vision Pro Users Trying Out New Headset On The Streets Leave Netizens Bewildered
Expressing disappointment with the court’s ruling, AliveCor issued a statement affirming its intention to pursue an appeal. Conversely, Apple responded with a statement emphasising the lawsuit’s challenge to its ability to innovate and enhance the Apple Watch for consumers and developers alike, asserting that the court’s decision validates the company’s position against allegations of anticompetitive behaviour.
When Did The Dispute Begin?
The legal dispute originated from AliveCor’s claims that Apple had initially indicated a potential collaboration in heart-monitoring technology for the Apple Watch, only to subsequently replicate its concepts and allegedly monopolise the heart rate analysis market. AliveCor further contended that Apple had modified its heart rate algorithm to impede third-party developers from identifying irregular heartbeats and creating competing applications.
ALSO READ: These Apple Devices May Be Prone To Cyber-Attacks, Security Agency Warns
Among AliveCor’s innovations is the KardiaBand, an accessory for the Apple Watch capable of recording electrocardiograms (ECGs). Additionally, the company developed the Kardia app, facilitating the analysis of ECG readings on Apple Watches, along with the SmartRhythm heart rate analysis app leveraging artificial intelligence.
Apple, headquartered in Cupertino, California, refuted the allegations, maintaining its stance against accusations of misconduct and asserting its prerogative to make independent design decisions without undue influence from competitors.
The legal battle between AliveCor and Apple continues, with AliveCor concurrently pursuing separate claims of patent infringement against the tech giant.